A Vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles

Poxviruses and Alphaviruses constitute two promising viral vectors that have been used extensively as expression systems, or as vehicles for vaccine purposes. Poxviruses, like vaccinia virus (VV) are well-established vaccine vectors having large insertion capacity, excellent stability, and ease of administration. In turn, replicons derived from Alphaviruses like Semliki Forest virus (SFV) are potent protein expression and immunization vectors but stocks are difficult to produce and maintain. In an attempt to demonstrate the use of a Poxvirus as a means for the delivery of small vaccine vectors, we have constructed and characterized VV/SFV hybrid vectors. A SFV replicon cDNA was inserted in the VV genome and placed under the control of a VV early promoter. The replicon, transcribed from the VV genome as an early transcript, was functional, and thus capable of initiating its own replication and transcription. Further, we constructed a VV recombinant additionally expressing the SFV structural proteins under the control of a vaccinia synthetic early/late promoter. Infection with this recombinant produced concurrent transcription of the replicon and expression of SFV structural proteins, and led to the generation of replicon-containing SFV particles that were released to the medium and were able to infect additional cells. This combined VV/SFV system in a single virus allows the use of VV as a SFV delivery vehicle in vivo. The combination of two vectors, and the possibility of generating in vivo single-cycle, replicon containing alphavirus particles, may open new strategies in vaccine development or in the design of oncolytic viruses. © 2013 Sánchez-Puig et al.

Saved in:
Bibliographic Details
Main Authors: Sánchez-Puig Eyre, Juana María, Lorenzo Gilsanz, María Mar, Blasco Lozano, Rafael
Format: journal article biblioteca
Language:English
Published: Public Library of Science 2013
Online Access:http://hdl.handle.net/20.500.12792/4119
http://hdl.handle.net/10261/294561
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-inia-es-10261-294561
record_format koha
spelling dig-inia-es-10261-2945612023-02-20T10:39:52Z A Vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles Sánchez-Puig Eyre, Juana María Lorenzo Gilsanz, María Mar Blasco Lozano, Rafael Poxviruses and Alphaviruses constitute two promising viral vectors that have been used extensively as expression systems, or as vehicles for vaccine purposes. Poxviruses, like vaccinia virus (VV) are well-established vaccine vectors having large insertion capacity, excellent stability, and ease of administration. In turn, replicons derived from Alphaviruses like Semliki Forest virus (SFV) are potent protein expression and immunization vectors but stocks are difficult to produce and maintain. In an attempt to demonstrate the use of a Poxvirus as a means for the delivery of small vaccine vectors, we have constructed and characterized VV/SFV hybrid vectors. A SFV replicon cDNA was inserted in the VV genome and placed under the control of a VV early promoter. The replicon, transcribed from the VV genome as an early transcript, was functional, and thus capable of initiating its own replication and transcription. Further, we constructed a VV recombinant additionally expressing the SFV structural proteins under the control of a vaccinia synthetic early/late promoter. Infection with this recombinant produced concurrent transcription of the replicon and expression of SFV structural proteins, and led to the generation of replicon-containing SFV particles that were released to the medium and were able to infect additional cells. This combined VV/SFV system in a single virus allows the use of VV as a SFV delivery vehicle in vivo. The combination of two vectors, and the possibility of generating in vivo single-cycle, replicon containing alphavirus particles, may open new strategies in vaccine development or in the design of oncolytic viruses. © 2013 Sánchez-Puig et al. 2023-02-20T10:39:52Z 2023-02-20T10:39:52Z 2013 journal article PLoS ONE 8(10): e75574 (2013) http://hdl.handle.net/20.500.12792/4119 http://hdl.handle.net/10261/294561 10.1371/journal.pone.0075574 1932-6203 en open Public Library of Science
institution INIA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-inia-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del INIA España
language English
description Poxviruses and Alphaviruses constitute two promising viral vectors that have been used extensively as expression systems, or as vehicles for vaccine purposes. Poxviruses, like vaccinia virus (VV) are well-established vaccine vectors having large insertion capacity, excellent stability, and ease of administration. In turn, replicons derived from Alphaviruses like Semliki Forest virus (SFV) are potent protein expression and immunization vectors but stocks are difficult to produce and maintain. In an attempt to demonstrate the use of a Poxvirus as a means for the delivery of small vaccine vectors, we have constructed and characterized VV/SFV hybrid vectors. A SFV replicon cDNA was inserted in the VV genome and placed under the control of a VV early promoter. The replicon, transcribed from the VV genome as an early transcript, was functional, and thus capable of initiating its own replication and transcription. Further, we constructed a VV recombinant additionally expressing the SFV structural proteins under the control of a vaccinia synthetic early/late promoter. Infection with this recombinant produced concurrent transcription of the replicon and expression of SFV structural proteins, and led to the generation of replicon-containing SFV particles that were released to the medium and were able to infect additional cells. This combined VV/SFV system in a single virus allows the use of VV as a SFV delivery vehicle in vivo. The combination of two vectors, and the possibility of generating in vivo single-cycle, replicon containing alphavirus particles, may open new strategies in vaccine development or in the design of oncolytic viruses. © 2013 Sánchez-Puig et al.
format journal article
author Sánchez-Puig Eyre, Juana María
Lorenzo Gilsanz, María Mar
Blasco Lozano, Rafael
spellingShingle Sánchez-Puig Eyre, Juana María
Lorenzo Gilsanz, María Mar
Blasco Lozano, Rafael
A Vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles
author_facet Sánchez-Puig Eyre, Juana María
Lorenzo Gilsanz, María Mar
Blasco Lozano, Rafael
author_sort Sánchez-Puig Eyre, Juana María
title A Vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles
title_short A Vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles
title_full A Vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles
title_fullStr A Vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles
title_full_unstemmed A Vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles
title_sort vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles
publisher Public Library of Science
publishDate 2013
url http://hdl.handle.net/20.500.12792/4119
http://hdl.handle.net/10261/294561
work_keys_str_mv AT sanchezpuigeyrejuanamaria avacciniavirusrecombinanttranscribinganalphavirusrepliconandexpressingalphavirusstructuralproteinsleadstopackagingofalphavirusinfectioussinglecycleparticles
AT lorenzogilsanzmariamar avacciniavirusrecombinanttranscribinganalphavirusrepliconandexpressingalphavirusstructuralproteinsleadstopackagingofalphavirusinfectioussinglecycleparticles
AT blascolozanorafael avacciniavirusrecombinanttranscribinganalphavirusrepliconandexpressingalphavirusstructuralproteinsleadstopackagingofalphavirusinfectioussinglecycleparticles
AT sanchezpuigeyrejuanamaria vacciniavirusrecombinanttranscribinganalphavirusrepliconandexpressingalphavirusstructuralproteinsleadstopackagingofalphavirusinfectioussinglecycleparticles
AT lorenzogilsanzmariamar vacciniavirusrecombinanttranscribinganalphavirusrepliconandexpressingalphavirusstructuralproteinsleadstopackagingofalphavirusinfectioussinglecycleparticles
AT blascolozanorafael vacciniavirusrecombinanttranscribinganalphavirusrepliconandexpressingalphavirusstructuralproteinsleadstopackagingofalphavirusinfectioussinglecycleparticles
_version_ 1767603631379447808